MedicalPriceCheck.com
|

Idarucizumab (Praxbind) 2.5GM:50ML Cost Comparison

J3590 (HCPCS)

Cash prices (without insurance) for Idarucizumab (Praxbind) 2.5GM:50ML (CPT J3590) range from $1,988 to $1,988 across 1 hospitals in 1 state. The national average cash price is $1,988.

Idarucizumab (Praxbind) is a medication used to reverse the effects of a blood thinner called dabigatran. Patients who are taking dabigatran and need emergency surgery or have uncontrolled bleeding may be given idarucizumab to quickly stop the blood-thinning effects. The medication is administered through an intravenous (IV) line, and the entire procedure typically takes less than 30 minutes.

$1,988$1,988 · 1 hospitals

1 hospital
Cash Price
(No Insurance)
$1,988
Gross Charge
$3,975

No payer-negotiated rates available

Prices shown are sourced from hospital price transparency files published under the Hospital Price Transparency Rule. Actual costs may vary based on your insurance plan, specific clinical circumstances, and additional services required. These prices are not a quote or guarantee.

This site does not provide medical advice. Always consult with your healthcare provider and insurance company before making decisions about medical care. Learn more about our data sources.